Arcxis Gets Investment from In-Q-Tel

Arcxis received an undisclosed investment from In-Q-Tel, which it will use to accelerate development and commercialization of its nucleic acid sample preparation platform and diagnostic consumable product line.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.